Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
The potential benefit of neoadjuvant toripalimab plus axitinib in cases with clear cell renal cell carcinoma (ccRCC) and inferior vena cava tumor thrombus (IVC-TT) remains unclear. NEOTAX was a phase 2 study to investigate the efficacy and safety of neoadjuvant toripalimab plus axitinib in ...
UCLA researchers developed a non-invasive imaging method using 89Zr-TLX250 to detect clear-cell renal cell carcinoma. This technique demonstrated high sensitivity (85.5%) and specificity (87.0%), effectively identifying cancer in small renal masses.
(HealthDay News) — For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, ...
Quick reading of articles: Evidence analysis of the diagnostic value of Exosomal miRNA in renal cell carcinoma ABSTRACT Aim: This meta-analysis aims to evalu...
Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal cell carcinoma.
Zaorsky discusses the patient safety misconceptions around radiotherapy for RCC, and considering patient-reported outcomes in future randomized controlled trials.
Genenta Secures Approval for Innovative Trial for
Metastatic Renal Cell Cancer
...
"We think that radiation therapy is one of the best treatment options available for kidney cancer," says Nicholas Zaorsky, MD, MS.
Zaorsky discusses his team's ASTRO 2024 abstract showing clear benefit of radiotherapy and ablation in reduced kidney effects in patients with RCC.
Toni Choueiri, MD, discusses the rationale behind the drug combination of tivozanib and nivolumab in the TiNivo-2 study.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.